Alpa Laboratories Ltd.

View in App
73.70 +0.85 ▲1.2%

22 September 2023, 04:01:00 PM
Volume: 3,559

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alpalabs.in
Market Cap 155.07 Cr.
Enterprise Value(EV) 147.22 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 6.18 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 11.92 Trailing Twelve Months Ending 2023-06
Industry PE 37.50 Trailing Twelve Months Ending 2023-06
Book Value / Share 65.40 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.13 Calculated using Price: 73.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.10 Cr. 21,040,600 Shares
FaceValue 10
About Alpa Laboratories Ltd.
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise.

Alpa Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Alpa Laboratories Ltd. Performance

View details >>
1 Day
+1.17%
1 Week
-1.38%
1 Month
+6.38%
3 Month
+11.94%
6 Month
+34.69%
1 Year
+16.80%
2 Year
+41.19%
5 Year
+144.44%
10 Year
+1075.44%

Alpa Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -5.84 -1.60 7.61 2.68 2.92 1.03 1.86 6.97 12.29
Return on Capital Employed (%) -2.54 -0.89 9.61 6.59 5.47 3.26 3.09 10.42 16.81
Return on Assets (%) -4.07 -1.10 4.99 1.86 2.29 0.84 1.54 5.56 9.53

Alpa Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 88 87 93 95 98 98 100 108 122 135
Non Curr. Liab. 6 0 1 0 0 0 -1 0 5 2
Curr. Liab. 32 41 52 30 23 22 21 33 29 31
Minority Int.
Equity & Liab. 127 128 146 125 121 121 120 140 155 167
Non Curr. Assets 74 16 27 20 23 27 25 19 16 15
Curr. Assets 53 113 119 105 98 94 95 121 139 152
Misc. Exp. not W/O
Total Assets 127 128 146 125 121 121 120 140 155 167

Alpa Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 57 57 54 63 63 78 86 98 112 95
Other Income 1 3 6 5 5 5 3 4 11 13
Total Income 57 61 59 69 68 83 89 102 123 108
Total Expenditure -51 -55 -47 -56 -59 -77 -83 -90 -102 -90
PBIDT 6 6 12 12 9 6 6 12 21 18
Interest -2 -2 -1 -2 -1 -1 0 0 0 0
Depreciation -9 -6 -1 -3 -3 -3 -3 -1 -2 -1
Taxation 0 1 -3 -3 -2 -2 -1 -4 -5 -3
Exceptional Items -1 -2 0
PAT -5 -1 7 3 3 1 2 7 14 13
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -5 -1 7 3 3 1 2 7 14 13
Adjusted EPS -2 -1 3 1 1 0 1 3 7 6

Alpa Laboratories Ltd. Cash Flow

View details >>
Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 8 -2 -22 17 -13 -1 18 -2 2
Cash Fr. Inv. -2 37 -8 -2 -11 -15 -11 6 -16
Cash Fr. Finan. 4 7 -6 -15 9 -5 -1 0 5
Net Change 10 42 -36 0 -15 -20 5 4 -8
Cash & Cash Eqvt 10 53 17 37 21 1 6 11 3

Alpa Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 56.66 56.66 56.66 57.29 57.29 57.29 57.29 57.29 57.29
Public 43.34 43.34 43.34 42.71 42.71 42.71 42.71 42.71 42.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Alpa Laboratories Ltd. Announcements

View details >>
Sat, 09 Sep 2023
Intimation Of The Book Closure For AGM
Intimation of the Book Closure for AGM to be held on 29th September 2023.
Tue, 05 Sep 2023
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2022-23.
Mon, 28 Aug 2023
Promoter Re-Classification Updates
Promoter Re-classification updates

Alpa Laboratories Ltd. Technical Scans

View details >>
Fri, 22 Sep 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month

Alpa Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,508.75 1,131.60 -1.3%
Divi's Laboratories Ltd. 98,393.27 3,708.40 -1.0%
Cipla Ltd. 95,796.29 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. 92,004.31 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. 71,703.97 5,003.05 -0.3%
Mankind Pharma Ltd. 70,167.07 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. 62,653.02 1,853.55 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.19 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 66.64 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 30.73 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.48 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 107.60 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 54.74 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.79 1,853.55 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 7.50 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 3.93 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.75 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.47 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 5.73 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.54 1,853.55 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,853.55 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,853.55 -1.1%

Alpa Laboratories Ltd. FAQ's

What is Alpa Lab share price?
Can I buy Alpa Lab shares now?
What is the Market Cap of Alpa Lab?
What are the key metrics to analyse Alpa Lab?
What is the 52 Week High and Low of Alpa Lab?
What is the trend of Alpa Lab share price?